Healthcare
March 20, 2018 / 12:11 PM / a year ago

BRIEF-Durect Announces FDA Advisory Committee Meeting For Remoxy Er

1 Min Read

March 20 (Reuters) - Durect Corp:

* DURECT ANNOUNCES FDA ADVISORY COMMITTEE MEETING FOR REMOXY® ER

* DURECT CORP - ‍PRESCRIPTION DRUG USER FEE ACT (PDUFA) TARGET DATE FOR REMOXY ER NDA IS AUGUST 7, 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below